Glaukos公司正式宣告,其针对Preserflo™微型引流器的510(k)关键性研究已完成患者入组工作。这一里程碑式的进展,标志着该产品上市进程迈出了关键一步。
Glaukos公司正式宣告,其针对Preserflo™微型引流器的510(k)关键性研究已完成患者入组工作。这一里程碑式的进展,标志着该产品上市进程迈出了关键一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.